Given the sensitive nature of many of the presentations at this meeting, your adherence to our social media policy is requested.

IASLC Newsletter - February 2018

In the last few years a series of quite complex projects, such as TracerX in United Kingdom, have flourished and generated data that has now been published.

The International Association for the Study of Lung Cancer (IASLC) welcomes Dave Mesko as its new Managing Director.

IASLC Newsletter - January 2018

It's anticipated that precision medicine will improve all areas of medicine, including the ability to predict an individual’s risk of disease, the disease prognosis and the risk of side effects versus positive response to treatment approaches.

Two leading international lung cancer organizations, the International Association for the Study of Lung Cancer (IASLC) and British Thoracic Oncology Group (BTOG), are partnering to use the BTOG annual conference, held January 24-26, 2018 in Dublin, Ireland, to highlight and inform about changes to the international system of staging lung cancer.

Rapid advancements in the molecular diagnostic testing of lung cancer have led to new treatments and greater hope for patients battling lung cancer, the most common cause of cancer death worldwide.